期刊文献+

突变型人肿瘤坏死因子-α工程菌发酵培养的实验研究 被引量:5

Study on fermentation of recombinant bacterial strain of human mutant tumor necrosis factor-α
下载PDF
导出
摘要 目的 优化基因重组人突变型 4 71肿瘤坏死因子 α(TNF α)工程菌的发酵和表达条件。方法 通过改变培养基的组分、pH值、培养温度和诱导表达的条件等 ,采用测定细菌生物量和蛋白表达量等方法 ,确定最适的发酵和表达条件 ,并考察工程菌中重组质粒的遗传稳定性。结果 突变型 4 71rhTNF α工程菌在 pH值 7.5的SOC培养基中 ,30℃培养、4 2℃诱导 5h时 ,其表达量最大。而且 ,所构建的重组质粒在工程菌DH5α中传代稳定 ,目的蛋白的表达不受影响。结论 优化了基因重组人突变型 4 71rhTNF α工程菌的发酵和表达的最适条件 ,为进一步开发人突变型 4 71rhTNF Objective To optimize the conditions for the fermentation of human mutant 471 TNF α engineering bacterial strain. Methods We measured the biomass of the engineering bacteria and detected the SDS PAGE of target protein to determine the optimal conditions for fermentation and expression by changing the cultures, the values of pH,the cultural temperatures and the time of induced expression. The inheritance stability of the recombinant plasmid of mutant 471 rhTNF α was also analyzed. Results The highest bacterial yield and expression ratio of mutant 471 rhTNF α in recombinant bacterial strain were observed in SOC medium with a pH value of 7.5 , the culture temperature 30?℃ and the highest expression yield of mutant 471 rhTNF α were obtained after 5 hour induction at 42?℃. Furthermore, the recombinant plasmid was proved to have been inherited steadily in DH5α with stable expression of the target protein. Conclusion We obtained the optimal conditions for the fermentation and expression of the engineering bacterial strain of human mutant 471TNF α, which lays a solid foundation for further research on mutant 471 rhTNF α.
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2003年第3期211-214,共4页 Journal of Xi’an Jiaotong University(Medical Sciences)
关键词 突变型人肿瘤坏死因子-α 工程菌 发酵 培养 实验 重组质粒 遗传稳定性 肿瘤细胞 human mutant 471TNF α fermentation engineering bacteria
  • 相关文献

参考文献1

共引文献3

同被引文献56

  • 1李凤梅,郭书海,牛之欣,牛明芬,冷延慧,张春桂.稠油降解菌的筛选及其对胶质和沥青质生物降解[J].土壤通报,2006,37(4):764-767. 被引量:21
  • 2包建平,朱俊章,朱翠山,易绍兴,倪春华.原油生物降解模拟实验[J].石油勘探与开发,2007,34(1):43-47. 被引量:21
  • 3Cheng Suna; Jian-Wen Wanga; I.ei Fanga; et al. , Free radical scavenging and antioxidant aetlvitles of EPS2, an exopolysaccharide produced by a marine filamentous fungus Keisslefiella sp. YS 4108,Life Sciences ,2004,75 : 1063-1073. 被引量:1
  • 4Thomas Ouellette; Sophie Destrau; Timothy Ouellette; et al. ,Production and purification of refolded recombinant human IL-7 from inclusion bodies, Protein Expression and Purification, 2003 , (30):156-166. 被引量:1
  • 5Youngjin Byun; Marl Ohmura; Kohtaro Fujihashi; et al. , Nasal immunization with E. eoli verotoxin 1 (VT1)-B subunit and a nontoxie mutant of eholera toxin elicits serum neutralizing antibodies ,Vaccine, 2001,19 : 2061-2070. 被引量:1
  • 6Qi Gaofu; Mao Dan; Wu Jie; et al. , Long-lasting specific antibodies against CETP induced by subcutaneous and mucosal administration of a 26-amino acid CETP epitope carried by heat shock protein 65 kDa in the absence of adjuvants , Vaccine, 2004 , (22):3187-3194. 被引量:1
  • 7Daan J. A. Crommelin; Gert Storm; Ruud Verrijk; et al. , Shifting paradigms: biopharmaeeuticals versus low molecular weight drugs,International Journal of Pharmaceuties, 2003, (266) :3-16. 被引量:1
  • 8Helena Engman; Christer Tannergren; Per Artursson; et al. ,Enantioselective transport and CYP3A4-mediated metabolism of R/S-verapamil in Caeo-2 cell monolayers, European Journal of Pharmaceutical Sciences, 2003, (9) : 57-65. 被引量:1
  • 9Masegi T,Kato A,Kitai K,et al.Characterization of a novel human tumor necrosis factor-alpha mutant with increased cytotoxic activity [J].Jpn J Cancer Res,1995; 86(1):72-80. 被引量:1
  • 10Lejeune F,Lienard D,Eggermont A,et al.Clinical experience with high-dose tumor necrosis factor alpha in regional therapy of advanced melanoma [J].Circ Shock,1994;43(4):191-197. 被引量:1

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部